FDA
approval
· 2017-07-11
FDA Approved: ADAPALENE — Supplemental Application (CALL INC. (dba Rochester Pharmaceuticals))
Summary
FDA approved a supplemental application for adapalene, signaling changes to the existing approval (e.g., labeling or formulation).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ADAPALENE (ADAPALENE)